5th Circuit Blocks Mail-Order Mifepristone
Key Questions
What did the 5th U.S. Circuit Court of Appeals rule on mail-order mifepristone?
The court issued a unanimous ruling halting nationwide mail-order dispensing of mifepristone from a Louisiana lawsuit. It reinstates the in-person dispensing requirement previously set by the FDA.
How does this ruling impact telehealth access to mifepristone?
The decision limits telehealth access by prohibiting mail-order distribution, requiring patients to obtain mifepristone in person. This affects abortion pill availability across the U.S.
What is expected to happen next after the 5th Circuit's ruling?
An appeal to the Supreme Court is anticipated amid ongoing legal battles following Roe v. Wade. The case stems from challenges to FDA regulations on mifepristone.
Unanimous ruling halts FDA nationwide mail dispensing from LA suit; reinstates in-person rule, impacts telehealth access ~2/3 abortions. SCOTUS appeal expected amid post-Roe fights.
Sources (1)
Updated May 6, 2026